EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSDORG00000006690
Gene Symbol: DHCR24
3 Cross references
209 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSDORG00000005455
Gene Symbol: HMGCR
2 Cross references
272 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSDORG00000011938
Gene Symbol: PDPK1
3 Cross references
244 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSDORG00000005248
Gene Symbol: HPD
3 Cross references
207 Possible Orthologues:

40s Ribosomal Protein S3a

Ensembl ID : ENSDORG00000029506
Gene Symbol: LOC105990081
3 Cross references
208 Possible Orthologues:

40s Ribosomal Protein S4-Like

Ensembl ID : ENSDORG00000029715
Gene Symbol: LOC105983725
3 Cross references
184 Possible Orthologues:

40s Ribosomal Protein S8-Like

Ensembl ID : ENSDORG00000023197
Gene Symbol: LOC105997722
2 Cross references
185 Possible Orthologues:

5 Hydroxytryptamine (Serotonin) Receptor 4

Ensembl ID : ENSDORG00000011917
Gene Symbol: HTR4
1 Cross references
201 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSDORG00000025003
Gene Symbol: NT5E
4 Cross references
248 Possible Orthologues:

5-Hydroxytryptamine Receptor 1a

Ensembl ID : ENSDORG00000026772
Gene Symbol: HTR1A
4 Cross references
150 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSDORG00000001316
Gene Symbol: HTR1B
3 Cross references
244 Possible Orthologues:

5-Hydroxytryptamine Receptor 1d

Ensembl ID : ENSDORG00000024913
Gene Symbol: HTR1D
3 Cross references
67 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).